  Human {\alpha}-synuclein (SNCA) is a 140-amino-acid protein belonging to the
three-member synuclein family. It has been extensively studied due to its
misfolding/aggregation in and genetic linkage to neurodegenerative diseases,
especially Parkinson's disease (PD). To better understand its biology, models
of SNCA toxicity have been developed in budding yeast over the past decade,
which have yielded insights into the protein's modes of action in specific
pathways and potential therapeutic targets. Given that the synuclein gene
family is not present in yeast, an extensive homology search was undertaken to
determine if any yeast protein may possess structural homology to SNCA and
whose native biology may shed more light on SNCA's pathomechanism in
eukaryotes. We identified Zeo1, a membrane-associated protein involved in the
cell wall integrity (CWI) pathway, as a candidate structural homolog. We show
that Zeo1 overexpression is toxic in yeast and, similar to SNCA, localizes to
lipid membranes. A number of biochemical similarities between Zeo1 and SNCA
also become apparent in light of this potential structural connection.
Moreover, the yeast PKC1 gene, a kinase acting as a downstream signaling hub in
the CWI pathway, rescues both SNCA- and Zeo1-induced toxicities. Using the same
homology search methods that identified Zeo1, we show that Pkc1 has a hybrid
structural similarity to PINK1 and PARIS, two mitochondrial PD-implicated
proteins not generally linked directly to synuclein-specific pathobiology.
Overall, this proof-of-concept study shows the potential utility of hitherto
uncharacterized cross-species structural homologs, identified using comparative
proteome-wide structure prediction algorithms, in shedding light on abstruse
connections among disease-relevant proteins.
